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a  b  s  t  r  a  c  t
The  accumulation  of  advanced  glycation  end  products  (AGE)  plays  signiﬁcant  role  in devel-
oping tubular  hypertrophy  during  diabetic  nephropathy  (DN).  Reactive  oxygen  species
and  nitric  oxide  (NO) are  directly  involved  in  the  progression  of  DN.  We  have  studied
the  effect  of  standardized  Gymnemasylvestre  organic  extract  (GE)  on  AGE  induced  cellu-
lar hypertrophy  using  rat renal tubular  epithelial  cells  (NRK  52E).  AGE  (400 g/ml)  induced
cytotoxicity  to NRK  52E  cells  as  determined  by MTT assay  at 0–72 h. We  report  cellular
hypertrophy  mediated  cytotoxicity  by AGE  which  was  the result  of signiﬁcant  reduction  in
the cellular  nitric  oxide  and  cGMP  levels  associated  with  increased  lipid peroxidation  and
antioxidant  depletion  (P <  0.05).  Upon  treatment  with  GE  the cell  viability  was  increased
with  reduced  cellular  hypertrophy  by  1.7  folds when  compared  to AGE treated  group.  GE
could signiﬁcantly  increase  NO by  1.9 folds  and  cGMP  by  2.8 folds  and  inhibited  GSH  deple-
tion  by  50%  during  AGE  induced  toxicity.  The  antioxidant  enzyme  activity  of catalase  was
increased  by  50%  while,  glutathione  peroxidase  and  superoxide  dismutase  enzyme  activi-
ties were  signiﬁcantly  increased  by  42%  and  67%  with  decreased  lipid  peroxidation  (49%)
upon GE treatment.  Thus,  GE attenuates  AGE  induced  hypertrophic  growth  by inhibiting
GSH  depletion  and  partly  through  increased  NO/cGMP  signaling.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
Y-NC-Nthe CC  BAbbreviations: AGE, advanced glycation end products; NO, nitric
oxide; cGMP, cyclic guanosine monophosphate; DN, diabetic nephropa-
thy; GE, Gymnemasylvestre organic extract; GSH, reduced glutathione;
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glutathione peroxidase; LPO, lipid peroxidation.
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1. Introduction
Diabetic nephropathy (DN), a major microvascular com-
plication of diabetes mellitus (DM) increases the risk of
life  threatening end-stage renal disease [36,1]. High glu-
cose  and advanced glycation end products (AGE) play a
vital  role in the development of DN [2,3]. AGE arise from
glucose-derived Amadori (1-deoxy-d-fructosyl deriva-
tives) products and act to increase oxidative stress, elevate
vascular permeability, enhance protein and lipoprotein
deposition, promote extracellular matrix (ECM) protein
is is an open access article under the CC BY-NC-ND license
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ynthesis, and tubulointerstitial ﬁbrosis, and exert a num-
er  of toxic effects on renal cells [3–5]. AGE mediate their
ffects  via speciﬁc receptors (RAGE), activating diverse
ignal transduction cascades, and downstream pathways,
ncluding generation of generalized cellular dysfunction
nd via reactive oxygen species [3–5].
Nitric oxide (NO) modulates large variety of physio-
ogical functions and initiates diverse cellular signaling
ascades which comprise nitrosylation of proteins, adeno-
ine  5′-diphosphate (ADP)-ribosylation, or stimulation
f soluble guanylylcyclases which catalyze intracellular
uanosine 3′,5′-cyclic monophosphate (cGMP) synthesis
6].  cGMP activates cGMP dependent protein kinase (PKG)
hich  mediate localized and global signaling. Consider-
ble evidence suggests that advanced DN leading to severe
roteinuria, declining renal function, and hypertension is
ssociated  with a state of progressive NO deﬁciency [6].
Protective effects of exogenously administered antiox-
dants have been extensively studied in animal models
7].  N-acetylcysteine (NAC), a thiol-containing radical scav-
nger  and glutathione precursor, has been found to protect
-cells  in culture and in vivo from “glucose toxicity” pre-
erving insulin synthesis and secretion [8]. In similar lines
aurine  act as an antiglycative compound, providing free
mino  groups that may  compete for the reducing sugars
7–9].
Rat  renal tubular epithelial cells (NRK-52E) are widely
sed to study the DN related complications in vitro [10].
RK-52E cells exposed to AGE-modiﬁed BSA (AGE-BSA; 40
icroM)  or TGF-beta1 (10 ng/ml) readily undergoes tran-
ition  from epithelial to mesenchymal cells a characteristic
eature of renal ﬁbrosis in experimental diabetes [10] and
ualiﬁes  as a good model to study DN related complica-
ions.
In this context natural compounds from herbal origin
hich can enhance the NO production and possess strong
ntioxidant might be beneﬁcial in attenuating the unde-
ired  effects of AGE might be beneﬁcial in retarding the
isk  of life threatening end-stage renal disease. Gymne-
asylvestre has been extensively used to treat diabetes
nd related complications from time immemorial [11,12].
part  from this it has been reported that Gymnemasylvestre
s beneﬁcial in the treatment of obesity, arthritis, hyper-
ipidemia, Parkinsonism, hypercholesterolemia [13,38,14].
n  light of these reports in the present study Gymnema-
ylvestre organic extract (GE) was evaluated in vitro using
at  renal tubular epithelial cells during AGE induced DN
ssociated complications.
.  Materials and methods
.1.  Chemicals
Bradford reagent, cytochrome-C, 2,7-
ichloroﬂuorescein diacetate, diphenylamine (DPA),
ulbecco’s Minimum Essential Medium (DMEM), d-
ibose,  Fetal bovine serum (FBS), glutathione (GSH),
ydrogen peroxide, 3(4,5-dimethyl thiazol-2-yl) 2,5-
iphenyl tetrazolium bromide (MTT), -Nicotinamide
denine dinucleotide phosphate (-NADPH), Phosphate
uffered saline (PBS), Perchloric acid, thiobarbituric acid,Reports 1 (2014) 834–842 835
d-Ribose,  Sodium cholate, Sodium dodecyl sulphate (SDS),
Tween-20, xanthine and xanthine oxidase were purchased
from Sigma-Aldrich (St. Louis, MO,  USA). All other reagents
were  of analytical grade.
2.2.  Gymnemasylvestre organic extract and marker
compound analysis
Standardized Gymnemasylvestre organic extract (GE)
was  a gift from Phytochemistry Division, The Himalaya
Drug Company, Bangalore, India. Brieﬂy, 25 kg of the leaves
of  Gymnemasylvestre was pulverized to ﬁne powder and
subjected to hot water extraction. The resultant extract
was spray dried and analyzed for gymnemic acid an active
marker  found in Gymnemasylvestre bygravimetric analysis.
The  net yield of the standardized extract based on gym-
nemic acid was found to be 20%. The good agricultural and
collection  practices (GACP) were employed during farming,
harvesting and collection of plant. The plant Gymnema-
sylvestre was identiﬁed and certiﬁed by Botanist and a
voucher specimen of the same has been archived in the
herbarium of R&D, The Himalaya Drug Company, Banga-
lore,  India.
2.3.  Preparation of AGE
Aliquots  of FBS were incubated for 7 days at 37 ◦C
in  the presence of 50 mM d-ribose plus 1% antibiotic-
antimycotic solution and then extensively dialyzed (10 kD
cut  off) against sodium phosphate saline buffer (PBS) 0.1 M
pH  7.4, to remove surplus sugar (glycated serum, GS). Fur-
ther  aliquots of FBS were processed in the same way, but
without  ribose (non-glycated serum, NGS) [15]. GS serum
aliquots were stored at◦20 ◦C until 3 days, and before each
experimental procedure the presence of AGE was evaluated
using  CircuLexTMCML/N-(carboxymethyl) lysine ELISA kit
(MBL  International Corporation, USA) according to manu-
facturer’s instruction. Thus prepared AGE was used in all
the  experiments.
2.4. Cell culture
All  the experiments were performed using NRK 52E
cells within 10 passages after thawing. The NRK 52E cells
(Rat  renal tubular epithelial cell line) was  obtained from
the  National Centre for Cell Science (NCCS) Pune, India,
were maintained in culture using 25 cm2 polystyrene ﬂasks
(Tarsons) with DMEM containing 10% FBS, 1% antibiotic-
antimycotic solution, and 3.7 g/L sodium bicarbonate under
an  atmosphere of 5% CO2 at 37 ◦C with 95% humidity. Con-
tinuous cultures were maintained by sub-culturing cells
every  4 days at 2.2 × 106 cells/25 cm2 ﬂasks by trypsination.
2.5. AGE induced cytotoxicity and protection by GE
NRK 52E cells were plated into 96-multiwell culture
plates from the stock containing 1 × 105 cells/ml and each
well  was seeded with ≈20,000 cells. To study AGE induced
cytotoxicity, 24 h after plating, the medium was discarded
and  fresh medium containing AGE at various concentra-
tions (100–500 g/ml) was  added. At different time points
icology 836 S. Vidyashankar et al. / Tox
(0–72 h), cellular viability was determined by the MTT
assay [16]. In order to determine the non-toxic concen-
tration of GE cells were incubated for 0–72 h and the
cytotoxicity was determined. Based on the experimen-
tal results the effective concentration was determined as
200  g/ml and used in all the experiments to evaluate the
protective potential of GE on several cellular parameters.
2.6. Estimation nitric oxide, cGMP, lipid peroxidation,
glutathione level during AGE treatment in NRK 52E cells
NRK  52E cells were grown in 24 well plates until
it reached 70% conﬂuence. Further culture media was
replaced by serum free DMEM supplemented with BSA,
AGE  with or without GE extracts along with experimental
controls were added. Twenty-four hours later, cell culture
medium and cell scrapings were harvested and kept at
−80 ◦C for following quantiﬁcation of several parameters.
Cell scrapings were harvested in lysis buffer (25 mM
KH2PO4, 2 mM MgCl2, 5 mMKCl, 1 mM EDTA, 1 mM EGTA,
100 M PMSF, pH 7.5) after rinsing the cells with PBS (pH
7.4).
2.7.  Biochemical analysis
2.7.1.  Determination of nitrite
Brieﬂy, nitrite was determined spectrophotometri-
cally by using the Griess reagent (0.1% N-1-naphthylene
ethylenediaminehydrochloride, 1% sulfanilamide in 5%
phosphoric acid as described previously [17]). Absorbance
was measured at 540 nm and nitrite concentration was
determined using sodium nitrite as a standard.
2.7.2. cGMP assay
The  cGMP was measured using commercially available
enzyme linked immunosorbant assay (ELISA) (Cayman,
USA) following the user guide provided with kit.
2.7.3. Lipid peroxidation and ROS estimation
The extent of lipid peroxidation was estimated by the
levels  of malondialdehyde measured using the thiobar-
bituric acid reactive substances (TBARS) assay at 535 nm
[18].  The results are expressed as nmol/mg of protein
using a molar extinction coefﬁcient of 1.56 × 105 MC  m−1.
The  accumulation of intracellular ROS was determined
by measuring DCF ﬂuorescence. Brieﬂy, 25 M (ﬁnal con-
centration) 2,7-dichloroﬂuorescein diacetate (DCFH-DA;
Sigma) was added to the culture medium treated with
or  without GE and AGE and incubated for 30 min  in the
regular culture conditions. Further excess DCFH-DA was
removed  and cells were lysed with lysis buffer and DCF
ﬂuorescence was quantiﬁed (excitation = 485 nm,  emis-
sion  = 530 nm)  using multi-detection microplate reader
Synergy-HT from BioTek instruments, Inc. Highland Park,
Winooski, Vermont, USA.
2.7.4.  Measurement of non-enzymic antioxidants
Cells were homogenized in trichloroacetic acid (5% w/v),
and  deproteinized supernatant was used for GSH assay.
The  glutathione content in the cell homogenate was  deter-
mined  by the DTNB-GSSG reductase recycling assay asReports 1 (2014) 834–842
previously described [19]. The results are expressed as
nmol  GSH/mg of protein.
2.7.5.  Measurement of enzymic antioxidants
The antioxidant enzymes superoxide dismutase (SOD),
catalase and glutathione peroxidase, (GPx) activities were
analyzed using cytosolic fraction. Total SOD activity was
determined by monitoring the inhibition of the reduction of
ferricytochrome C at 550 nm,  using the xanthine–xanthine
oxidase system as the source of superoxide. One unit of
the  SOD is deﬁned as the amount of the enzyme required
to  inhibit 50% of the rate of cytochrome C reduction [20].
Catalase activity was measured by following the rate of
H2O2 consumption spectrophotometrically at 240 nm and
expressed as mol  H2O2 oxidized/min/mg protein [21].
Glutathione peroxidase activity was determined by follow-
ing  the enzymatic NADPH oxidation at 340 nm [22].
2.8.  Cellular hypertrophy analysis
Cells were grown in six-well plates until 50% conﬂu-
ence and then made quiescent for 2 days in serum-free
DMEM (High Glucose) medium. The cultures were treated
with  BSA, AGE and with or without GE and experimental
control. At the end of experimental time the cell surface
area was analyzed for at least 30 cells per condition using
the  public ImageJ 1.47 software. Further, the cells were
trypsinized, washed twice with phosphate-buffered saline
(PBS)  and counted using a hemocytometer. Equal numbers
of  cells were lysed in buffer (0.1% [wt/vol] SDS, 0.5% [wt/vol]
sodium deoxycholate, 1% [wt/vol] Tween 20 in PBS). The
total  protein content was  measured using the Bio-Rad pro-
tein  assay kit. Total protein was  expressed as micrograms
of protein per 104 cells.
2.9.  Statistical analysis
Statistical  analysis was  carried out using Graph Pad
Prism statistical software (Graph Pad Prism, San Diego,
CA,  USA). Results are analyzed by t-test and one-way
analysis of variance (ANOVA) wherever applicable and
the  signiﬁcance was  calculated using the Tukey–Kramer
multiple comparison test and results are considered as
signiﬁcant at P < 0.05.
3. Results
3.1. AGE characterization by CML content and its
cytotoxicity
The AGE used throughout the experimentation was
characterized by analyzing CML  N-(carboxy methyl)
lysine. The results showed that AGE prepared by following
the  method detailed contained 16.07 ± 0.76 ng/ml of CML
(Fig.  1). Cytotoxicity of AGE and GE in NRK-52E cells was
evaluated using MTT  assay and the results are given in
Fig.  2(a) and (b). AGE was tested for its cytotoxicity with
wide  range of concentration for 0–72 h and the results are
given  in Fig. 2(a). On the other hand GE did not present
any cytotoxic effect at concentration ranging from 0 to
250  g/mL when tested for 0–72 h when tested against
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Fig. 1. Concentrations of CML/N-(carboxymethyl) lysine in non-glycated
serum sample and glycated serum sample (AGE). Glycated serum was
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irepared as described in Section 2. Values are mean ± SEM of three inde-
endent experiments carried out in triplicates. **Statistically signiﬁcant
t P < 0.05 compared to non-glycated serum.
ell control (data not shown). The results showed that
GE  at (100–500 g/ml) caused cytotoxicity to NRK-52E
ells. The CTC50 of AGE was determined to be 400 g/ml
AGE sample used in the experiments contained 40 ng
ML/mg AGE] at 72 h. Hence, the cells were challenged
ig. 2. Effect of various concentrations of AGE and GE on NRK-52E cell
ytotoxicity at 0–72 h. The cells were incubated with incremental con-
entrations of (a) AGE and (b) GE for 24, 48 and 72 h and the cytotoxicity
as determined as described in Section 2. Values are mean ± SEM of three
ndependent experiments carried out in triplicates.
Fig. 3. Effect of GE on (a) nitric oxide and (b) cGMP levels in NRK-52E cells.
The cells were incubated with AGE in the presence or absence of GE and
NO and cGMP levels were determined as described in Section 2. Values are
mean  ± SEM of three independent experiments carried out in triplicates.
**Statistically signiﬁcant at P < 0.05 compared to control. *Statistically sig-
niﬁcant at P < 0.05 compared to AGE.
against CTC50 in all the subsequent experiments for testing
protective effect of GE.
3.2.  Effect of GE on nitric oxide and cGMP levels upon
AGE treatment
The cells exposed to AGE were evaluated for nitric oxide
and  cGMP levels and the results are given in Fig. 3(a) and (b).
The  results showed that AGE inhibited the NO and cGMP by
64%  and 68.5% respectively in NRK-52E cells. Further, the
cells  when added with GE increased NO and cGMP levels
by  1.9 folds and 2.8 folds respectively compared to AGE
treated cells. Cells treated with antioxidant taurine shown
to  signiﬁcantly inhibit depletion of NO and cGMP by 1.7
folds  and 2.5 folds respectively compared to AGE group.
3.3.  Effect of GE on lipid peroxidation, ROS generation
and non-enzymic antioxidantsThe  lipid peroxidation was  signiﬁcantly increased by 3.2
folds  upon addition of AGE to NRK-52E cells as shown in
Fig.  4(a). The cells treated with antioxidant taurine could
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Fig. 4. Effect of GE on lipid peroxidation 4 (a) and ROS generation 4 (b)
during AGE induced cellular hypertrophy in NRK-52E cells. Cells were co-
incubated with BSA (400 g/ml), AGE (400 g/ml) in presence or absence
of GE (200 g/ml), or Taurine (100 M)  and the lipid peroxidation and ROS
was  determined at 24 h as described in Section 2. Taurine was used as neg-
ative control. Values are mean ± SEM of three independent experiments
carried out in triplicates. **Statistically signiﬁcant at P < 0.05 compared to
control. *Statistically signiﬁcant at P < 0.05 compared to AGE.
signiﬁcantly inhibit the lipid peroxidation (42%) induced
by  AGE. GE addition was  very effective and it signiﬁcantly
reduced the lipid peroxidation by 49% compared to AGE
treated  cells. The ROS generation in AGE treated group was
signiﬁcantly higher compared to control group whereas GE
addition  showed effectively inhibited the generation of ROS
as  given in Fig. 4(b).
The  effect of AGE treatment on GSH and GSSG levels in
NRK-52E cells was evaluated and the results are given in
Table  1. The results showed that non-enzymic antioxidant
glutathione content was signiﬁcantly reduced by 76.5%
upon  AGE treatment compared to control cells. While, addi-
tion  of GE and taurine to cells treated with AGE showed
to  inhibit GSH depletion by 50% and 29.1% respectively
when compared between control and AGE treated cells. The
AGE  treatment signiﬁcantly reduced the GSH/GSSG ratio
compared to control cells. But GE and taurine signiﬁcantly
increased the GSH/GSSG ratio. However increase in GSSG
content  is not proportional to depleted GSH in AGE treated
cells.Reports 1 (2014) 834–842
3.4.  Effect of GE on antioxidant enzyme activity
The antioxidant enzymes catalase, glutathione perox-
idase (GPx) and superoxide dismutase (SOD) activities
were evaluated and the results (Table 2) showed that AGE
inhibited the catalase activity by 63%. The GPx activity
was  inhibited by 49% and SOD activity was inhibited by
45%  respectively in AGE treated cells. Upon addition of GE
to  cells treated with AGE the catalase activity increased
signiﬁcantly by 2.2 folds, whereas GPX and SOD activity
were increased by 42% and 67% respectively compared to
AGE  treated group. In similar lines when the cells chal-
lenged with AGE were treated with taurine the antioxidant
enzyme activities were signiﬁcantly increased.
3.5. Effect of GE on hypertrophic growth
The effect of GE during AGE-mediated cellular hyper-
trophy was  studied and the results are presented in
Fig.  5(a)–(d). The results showed that AGE signiﬁcantly
reduced the cell viability by 52% and inhibited mitogen-
esis compared to control cells Fig. 5(a). Apart from cell
viability, cell number and relative cell surface area (%)
was  determined and the results are given in Fig. 5(b)
and  (c). The results showed that AGE treatment signiﬁ-
cantly decreased the cell number by 38.2% with increased
relative cell surface area by 25%. While in GE and tau-
rine treated groups decreased relative cell surface area by
18.1%  and 21.1% and increased cell number by 51% and
34.8%  respectively compared to AGE treated group. The
increased ratio of cellular protein content to cell num-
ber  represents the cellular hypertrophy and the results
showed that AGE increased signiﬁcantly the cellular hyper-
trophy  by 79% compared to control cells Fig. 5(d). While
GE  and taurine treated cells signiﬁcantly inhibited cellular
hypertrophy. The cell morphological characteristics were
analyzed by microscopy and the results are given as pho-
tomicrographs Fig. 6. The results clearly showed that cells
treated  with AGE exhibited profound hypertrophic charac-
teristics  while, treatment with GE and taurine successfully
inhibited the morphological changes associated with AGE
induced  hypertrophy.
4.  Discussion
DN is alarmingly increasing and is regarded as the com-
mon  cause for the end-stage renal failure requiring organ
replacement [2,9,23]. The molecular mechanism associ-
ated  with DN has been one of the most desired research
topics to be studied. In the present study it has been
showed that AGE mediates cytotoxicity to NRK-52E cells
when  incubated over a period of 0–72 h in an incremental
manner. Our observations are in agreement with ear-
lier  reports wherein it has been experimentally shown
that AGE alter the function and structure of tissue matrix
proteins and this result in triggering expression of var-
ious  pathogenic mediators through increased oxidative
stress, ECM, TGF-1, etc. which are implicated in the
development and induction of DN [3,4,24,25]. Clinically
it  has been consistently shown that AGE are involved in
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Table 1
Effect of GE on non-enzymic antioxidants during AGE induced cellular hypertrophy in NRK-52E cells. Cells were co-incubated with BSA (400 g/ml), AGE
(400  g/ml) in presence or absence of GE (200 g/ml), or Taurine (100 M) and non-enzymic antioxidants were determined at 24 h as described in Section
2.  Values are mean ± SEM of three independent experiments carried out in triplicates. **Statistically signiﬁcant at P < 0.05 compared to control. *Statistically
signiﬁcant  at P < 0.05 compared to BPA.
Groups GSH (nmol/mg protein) GSSG (nmol GSH equiv/mg protein) GSH/GSSG ratio
Control 94.65 ± 3.22* 11.58 ± 1.35* 8.18
BSA 91.84 ± 2.82* 14.32 ± 2.80* 6.41
AGE 22.25 ± 1.15** 20.37 ± 2.98** 0.53
AGE + Taurine 49.85 ± 4.12** 12.64 ± 3.41 1.81
AGE + GE 69.45 ± 3.22* 11.85 ± 2.32 4.42
ND—not detected.
Table 2
Effect of GE on antioxidant enzymes catalase, glutathione peroxidase and superoxide dismutase activity during AGE induced cellular hypertrophy in NRK-
52E  cells. Cells were co-incubated with BSA (400 g/ml), AGE (400 g/ml) in presence or absence of GE (200 g/ml), or Taurine (100 M)  and antioxidant
enzyme  activities were determined at 24 h as described in Section 2. Values are mean ± SEM of three independent experiments carried out in triplicates.
**Statistically signiﬁcant at P < 0.05 compared to control. *Statistically signiﬁcant at P < 0.05 compared to ethanol.
Groups Catalasea Glutathione peroxidiseb Superoxide dismutasec
Control 3.24 ± 0.21* 39.19 ± 2.75* 40.22 ± 2.56*
BSA 2.98 ± 0.16* 40.23 ± 3.65* 44.52 ± 3.22*
AGE 1.21 ± 0.35** 19.84 ± 1.38** 21.97 ± 1.31**
AGE + Taurine 2.10 ± 0.32** 24.58 ± 3.68** 25.44 ± 1.68**
AGE + GE 2.73 ± 0.49* 28.17 ± 2.12* 36.71 ± 2.17*
a moles of H2O2 decomposed/min/mg protein.
b moles of NADPH oxidized/min/mg protein.
c Units/mg protein.
Fig. 5. Effect of GE on AGE mediated cellular hypertrophy. Serum-deprived cells were treated with BSA (400 g/ml), AGE (400 g/ml) in presence or absence
of  GE (200 g/ml), or Taurine (100 M)  for 3 days, and then assayed for (a) cell viability (b) cell number (c) relative cell size and (d) hypertrophy index as
described  in Section 2. Values are mean ± SEM of three independent experiments carried out in triplicates. **Statistically signiﬁcant at P < 0.05 compared
to  control. *Statistically signiﬁcant at P < 0.05 compared to AGE.
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Fig. 6. Photomicrograph of NRK-52E cells treated with AGE (400 g/ml) in presence or absence of GE (200 g/ml) or Taurine (100 M)  for 3 days as
logical c
E (400 described  in the text. The cells were stained with 5% Giemsa and morpho
Cell  control, (b) cell treated with AGE (400 g/ml), (c) cells treated with AG
(200  g/ml).
the development and progression of glomersulosclerosis
and tubulointerstitial ﬁbrosis in patients with diabetes
[3–5].
Hyperglycemia is associated with the decrease in NO
production and the loss of NO-mediated repression of
aldose  reductase is a signiﬁcant factor in the activation
of the polyol pathway and the development of several
diabetic complications [26,27]. We  report that AGE sig-
niﬁcantly depletes NO and cGMP in NRK 52E cells which
might have been resulted due to the activation of polyol
pathway. Thus, compounds which increase NO generation
during AGE induced pathogenesis may  inhibit oxidative
stress induced by hyperglycemia. Earlier, nitric oxide syn-
thase  cofactor tetrahydrobiopterin has been successfully
shown to inhibit the generation of reactive oxygen species
(ROS)  [28–30]. In concurrence to the reports, cells exposed
to  AGE and treated with GE signiﬁcantly increased the
NO  measured as nitrate in cells followed with increased
cGMP levels to increase the cell viability. Hence, com-
pounds present in GE was mainly responsible in bringing
about increase cell viability through enhanced NO produc-
tion  and increased cGMP levels.
Several studies have suggested that AGE stimulates
production of ROS, including superoxide anions, hydro-
gen  peroxide and hydroxyl radicals, in a variety of
cell  types [3–5,7,31]. Antioxidants such as taurine can
increase the intracellular concentrations of glutathione
and augment cellular antioxidant capacity and can also
directly  scavange ROS [7,8,31]. Our ﬁndings show that
AGE  increased intracellular generation of ROS which ishanges were recorded using a Leica microscope at 10× magniﬁcation. (a)
g/ml) + Taurine (100 M)  and (d) cells treated with AGE (400 g/ml) + GE
reported  as increased lipid peroxides. Incubation of cells
with  GE and taurine signiﬁcantly decreased generation of
lipid  peroxides and ROS which is in agreement with earlier
reports [32]. These observations suggest for the ﬁrst time
that  GE acts as a strong antioxidant during AGE induced
complications.
It  is known that, GSH a non-enzymic antioxidant plays
an  important role in cellular defense against ROS, free radi-
cals  and electrophilic metabolites [33,34]. Hence, severe
GSH  depletion leaves cells more vulnerable to oxidative
damage by radicals and increases protein thiolation or
oxidation of SH groups that may  lead to alterations in cel-
lular  calcium homeostasis [34]. A sustained increase in
cytosolic calcium levels results in activation of enzymes
(phospholipases, non-lysomal proteases, endonucleases)
and cytoskeletal damage, which ultimately causes cell
death  [34]. The potential of GE to maintain GSH at rea-
sonably high levels is of importance against AGE induced
toxicity. Therefore, the ability of GE in preventing AGE
induced GSH depletion by 80% is very signiﬁcant in restor-
ing  the cell viability. The GSSG formation was  inhibited by
GE  and this may  be attributed to the formation of GSH con-
jugates  rather than oxidation to GSSG in AGE induced toxic
conditions.
Beside  these, cells secrete strong antioxidant enzymes
such as superoxide dismutase, catalase and glutathione
peroxidase to combat severe oxidative stress during
diseased/toxic conditions. Earlier it has been shown that
AGE  augment formation of ROS through depletion of
glutathione peroxidase [37]. We  also report in similar
icology 
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ines that AGE signiﬁcantly inhibited the antioxidant
nzyme activities of catalase, superoxide dismutase and
lutathione peroxidase. While AGE induced inhibition
f antioxidant enzyme activities was restored by treat-
ent  with GE with reduced ROS generation in cells. The
ncreased antioxidant enzyme activities were observed in
ells  treated with taurine and diclofenac too. These results
dd  to the fact that compounds in GE extract acts in similar
ines  with taurine to bring pharmacological action.
It  has been clearly shown in our study that cellular
ypertrophy is the characteristic feature in renal tubu-
ar  epithelial cells treated with AGE with reduced NO and
GMP  levels. Our observation is further substantiated with
he  earlier reports that AGE induced cellular hypertrophy
hrough iNOS/PKG inactivation followed with expres-
ion of ERK/JNK/p38 MAPK pathway and ﬁbronectin/p21
af1/Cip1 synthesis [35]. In addition we also report that
reatment with GE and taurine could effectively reduce
he  relative markers of cellular hypertrophy suggesting
hat GE effectively restores NO/cGMP levels to inhibit cel-
ular  differentiation observed during DN complications.
hus, it is inferred that standardized Gymnemasylvestre
rganic extract derived compounds inhibit GSH depletion
nd  increase cGMP and nitric oxide to attenuate advanced
lycation end products induced hypertrophic growth in
enal  tubular epithelial cells and warrants further studies.
ppendix A. Supplementary data
Supplementary data associated with this article can
e  found, in the online version, at doi:10.1016/j.toxrep.
014.08.015.
eferences
[1] P. Zimmet, K.G. Alberti, J. Shaw, Global and societal implications of
the  diabetes epidemic, Nature 414 (2001) 782–787.
[2]  K. Fukami, S. Yamagishi, S. Ueda, S. Okuda, Novel therapeutic tar-
gets  for diabetic nephropathy, Endocr. Metab. Immun. Disord. Drug
Targets  7 (2007) 83–92.
[3] T. Sato, M.  Iwaki, N. Shimogaito, X. Wu,  S. Yamagishi, M. Takeuchi,
TAGE (toxic AGE) theory in diabetic complications, Curr. Mol. Med. 6
(2006)  351–358.
[4] J.M. Bohlender, S. Franke, G. Stein, G. Wolf, Advanced glycation end
products and the kidney, Am.  J. Physiol. Renal Physiol. 289 (2005)
645–659.
[5]  A.L. Tan, J.M. Forbes, M.E. Cooper, AGE, RAGE, and ROS in diabetic
nephropathy, Semin. Nephrol. 27 (2007) 130–143.
[6]  M.C. Cerra, D. Pellegrino, Cardiovascular cGMP-generating systems
in  physiological and pathological conditions, Curr. Med. Chem. 14
(2007)  585–599.
[7] R. Da Ros, R. Assaloni, A. Ceriello, Antioxidant therapy in dia-
betic complications: what is new? Curr. Vasc. Pharmacol. 2 (2004)
335–341.
[8]  C.A. Haber, T.K. Lam, Z. Yu, N. Gupta, T. Goh, E. Bogdanovic, A. Giacca,
I.G.  Fantus, N-acetylcysteine and taurine prevent hyperglycemia-
induced insulin resistance in vivo: possible role of oxidative stress,
Am.  J. Physiol. Endocrinol. Metab. 285 (2003) E744–E753.
[9] D. Verzola, M.B. Bertolotto, B. Villaggio, L. Ottonello, F. Dallegri, G.
Frumento, V. Berruti, M.T. Gandolfo, G. Garibotto, G. Deferran, Tau-
rine  prevents apoptosis induced by high ambient glucose inhuman
tubule renal cells, J. Investig. Med. 50 (2002) 443–451.
10] W.C. Burns, S.M. Twigg, J.M. Forbes, J. Pete, C. Tikellis, V. Thallas-
Bonke, M.C. Thomas, M.E. Cooper, P. Kantharidis, Connective tissue
growth  factor plays an important role in advanced glycation
end product-induced tubular epithelial-to-mesenchymal transition:
implications for diabetic renal disease, J. Am. Soc. Nephrol. 17 (9)
(2006)  2484–2494.
[Reports 1 (2014) 834–842 841
11] E.R.B. Shanmugasundaram, G. Rajeswari, K. Baskaran, B.R.R. Kumar,
K.R.  Shanmugasundaram, B.K. Ahmath, Use of Gymnemasylvestre leaf
extract  in the control of blood glucose in insulin-dependent diabetes
mellitus, J. Ethnopharmacol. 30 (3) (1990) 281–294.
12]  K. Baskaran, B.K. Ahamath, K.R. Shanmugasundaram, E.R.B. Shan-
mugasundaram, Antidiabetic effect of a leaf extract from Gymne-
masylvestre in non-insulin-dependent diabetes mellitus patients, J.
Ethnopharmacol. 30 (3) (1990) 295–305.
13]  J.K. Malik, F.V. Manvi, B.R. Nanjware, D.K. Dwivedi, P. Purohit, S.
Chouhan, Anti-arthritic activity of leaves of Gymnemasylvestre R.Br.
leaves  in rats, Der Pharm. Lett. 2 (2010) 336–341.
14]  A.A. Spasov, M.P. Samokhina, A.E. Bulanov, Antidiabetic properties
of  Gymnemasylvestre (a review), Pharm. Chem. J. 42 (11) (2008)
22–26.
15]  A.M. Bassi, S. Ledda, M.C. Valentini, De. Pascale, S. Rossi, P. Odetti, D.
Cottalasso,  Damaging effects of advanced glycation end-products in
the  murine macrophage cell line J774A.1, Toxicol. in Vitro 16 (2002)
339–347.
16]  T. Mosmann, Rapid colorimetric assay for cellular growth and sur-
vival:  application to proliferation and cytotoxicity assays, J. Immunol.
Methods 65 (1983) 55–63.
17] F.K. Bell, J.J. O’Neill, R.M. Burgison, Determination of the oil/water
distribution co-efﬁcients of glyceryltrinitrate and two  similar nitrate
esters,  J. Pharmacol. Sci. 52 (1963) 637–639.
18]  H. Ohakawa, U. Ohishi, K. Yagi, Assay for lipid peroxides in ani-
mal  tissues by thiobarbituric reaction, Anal. Biochem. 95 (1979)
145–149.
19] M.E. Anderson, Determination of glutathione and glutathione
disulﬁde in biological samples, Methods Enzym. 113 (1985)
548–555.
20]  L. Flohe, O. Otting, Superoxide dismutase assays, Methods Enzym.
105  (1984) 93–104.
21] H. Aebi, Catalase in vitro, Methods Enzym. 105 (1984) 121–126.
22] L. Flohe, W.A. Gunzler, Assays of glutathione peroxidise, Methods
Enzym. 105 (1984) 114–121.
23] M.H. Schutta, Diabetes and hypertension: epidemiology of the
relationship and pathophysiology of factors associated with
these comorbid conditions, J. Cardiometab. Syndr. 2 (2007)
124–130.
24]  N.E. Cameron, T.M. Gibson, M.R. Nangle, M.A. Cotter, Inhibitors of
advanced glycation end product formation and neurovascular dys-
function  in experimental diabetes, Ann. N.Y. Acad. Sci. 1043 (2005)
784–792.
25]  H. Ha, H.B. Lee, Reactive oxygen species amplify glucose signalling
in  renal cells cultured under high glucose and in diabetic kidney,
Nephrology (Carlton) 10 (2005) 7–10.
26]  J.M. Forbes, K. Fukami, M.E. Cooper, Diabetic nephropathy: where
hemodynamics meets metabolism, Exp. Clin. Endocrinol. Diabetes
115  (2007) 69–84.
27] B.F. Schrijvers, A.S. De Vriese, A. Flyvbjerg, From hyperglycemia to
diabetic  kidney disease: the role of metabolic,hemodynamic, intra-
cellular  factors and growth factors/cytokines, Endocr. Rev. 25 (2004)
971–1010.
28]  S. Cai, J. Khoo, K.M. Channon, Augmented BH4 by gene transfer
restores nitric oxide synthase function in hyperglycemic human
endothelial cells, Cardiovasc. Res. 65 (2005) 823–831.
29] A. Miyazaki-Akita, T. Hayashi, Q.F. Ding, H. Shiraishi, T. Nomura,
Y. Hattori, A. Iguchi, 17beta-estradiol antagonizes the downreg-
ulation of endothelial nitric-oxide synthase and GTP cyclohydro-
lase I by high glucose: relevance to postmenopausal diabetic
cardiovascular disease, J. Pharmacol. Exp. Ther. 320 (2007)
591–598.
30]  S.S. Prabhakar, Tetrahydrobiopterin reverses the inhibition of nitric
oxide  by high glucose in cultured murine mesangial cells, Am.  J.
Physiol.  Renal Physiol. 281 (2001) 179–188.
31]  D.M. Niedowicz, D.L. Daleke, The role of oxidative stress in
diabetic complications, Cell Biochem. Biophys. 43 (2005)
289–330.
32]  J.S. Huang, L.Y. Chuang, J.Y. Guh, Y.L. Yang, M.S. Hsu, Effect of tau-
ring  on advanced glycation end products-induced hypertrophy in
renal  tubular epithelial cells, Toxicol. Appl. Pharmacol. 293 (2008)
220–226.
33]  G.L. Kedderis, Biochemical basis of hepatocellular injury, Toxicol.
Pathol. 24 (1996) 77–83.34] J.V. Castell, M.J. Gomez-Lechon, X. Ponsoda, R. Bort, In vitro
investigation of the molecular mechanisms of hepatotoxicity,
in: J.V. Castell, M.J. Gomez-Lechon (Eds.), In Vitro Methods
in Pharmaceutical Research, Academic Press, London, 1997,
pp. 375–410.
icology 
[
[
[842 S. Vidyashankar et al. / Tox
35] J.S. Huang, L.Y. Chuang, J.Y. Guh, Y.J. Huang, Effects of nitric oxide
and  antioxidants on advanced glycation end products-induced
hypertrophic growth in human renal tubular cells, Toxicol. Sci. 111
(1)  (2009) 109–119.
36] S. Giunti, D. Barit, M.E. Cooper, Mechanisms of diabetic nephropathy:
role of hypertension, Hypertension 48 (2006) 519–526.
[Reports 1 (2014) 834–842
37] T. Niwa, S. Tsukushi, 3-deoxyglucosone and AGEs in uremic compli-
cations: inactivation of glutathione peroxidase by 3-deoxyglucosone,
Kidney Int. Suppl. 78 (2001) s37–s41.
38] P.R. Rachh, M.R. Rachh, N.R. Ghadiya, et al., Antihyperlipidemic activ-
ity  of Gymenmasylvestre R.Br. leaf extract on rats fed with high
cholesterol diet, Int. J. Pharmacol. 6 (2) (2010) 138–141.
